- Protocol Short Name and Number: CALGB 100701/ BMT CTN 0804 CLL
- Protocol Long Name: Phase II Study of Reduced- Intensity Allogeneic Stem Cell Transplant For High Risk Chronic Lymphocytic Leukemia (CLL)
- For access to Protocol documents please visit the CTSU site: https://www.ctsu.org
- Key Personnel
- BMT CTN # 0804 Protocol Chair: Richard T. Maziarz, MD
- BMT CTN # 0804 Protocol Officer: Mary Horowitz, MD
- Alliance Regulatory Group: regulatory@alliancenctn.org
- Keywords: CALGB, 100701, Reduced Intensity, RIC, Chronic Lymphocytic Leukemia, CLL, Leukemia, Allogeneic Transplant, Allo Transplant, Allo, Unrelated, Unrelated Donor
This study has reached its final accrual goal; the study closed to new patient accrual on January 27, 2014.